Next, we asked whether inclusion of the wGII measure would impact prognosis consistent with the hypothesis that increased CIN in the context of an active cGAS-STING pathway would improve the immune response. The gene discussed is CGAS; the disease is cervical squamous intraepithelial neoplasia.